By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)

OTC Market Data in USD, Fundamentals in EUR
$65.44
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$13.45B
Market Cap
27.18
P/E Ratio (TTM)
2.30%
Forward Dividend Yield
$49.00 - $65.44
52 Week Range

RCDTF Stock Price Chart

Explore Recordati Industria Chimica e Farmaceutica S.p.A. interactive price chart. Choose custom timeframes to analyze RCDTF price movements and trends.

RCDTF Company Profile

Discover essential business fundamentals and corporate details for Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - General

IPO Date

17 Dec 2010

Employees

4.58K

CEO

Robert Koremans

Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

RCDTF Financial Timeline

Browse a chronological timeline of Recordati Industria Chimica e Farmaceutica S.p.A. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 May 2026

Upcoming earnings on 11 Feb 2026

Upcoming earnings on 11 Nov 2025

Earnings released on 30 Jul 2025

EPS came in at $0.82 falling short of the estimated $0.90 by -8.99%, while revenue for the quarter reached $758.13M , missing expectations by -0.33%.

Earnings released on 8 May 2025

EPS came in at $0.88 , while revenue for the quarter reached $745.41M , beating expectations by +1.33%.

Dividend declared on 18 Mar 2025

A dividend of $0.75 per share was announced, adjusted to $0.79. The dividend was paid on 21 May 2025.

Earnings released on 13 Feb 2025

EPS came in at $0.39 , while revenue for the quarter reached $619.72M , beating expectations by +2.68%.

Earnings released on 8 Nov 2024

EPS came in at $0.74 falling short of the estimated $0.76 by -2.25%, while revenue for the quarter reached $611.33M , missing expectations by -0.92%.

Earnings released on 30 Jul 2024

EPS came in at $0.70 surpassing the estimated $0.70 by +0.57%, while revenue for the quarter reached $621.32M , beating expectations by +3.10%.

Earnings released on 9 May 2024

EPS came in at $0.85 surpassing the estimated $0.75 by +14.09%, while revenue for the quarter reached $652.97M , missing expectations by -0.40%.

Earnings released on 22 Feb 2024

EPS came in at $0.61 surpassing the estimated $0.57 by +7.39%, while revenue for the quarter reached $578.65M , missing expectations by -0.46%.

Dividend declared on 30 Jan 2024

A dividend of $0.64 per share was announced, adjusted to $0.70. The dividend was paid on 20 Nov 2024.

Dividend declared on 30 Jan 2024

A dividend of $0.68 per share was announced, adjusted to $0.74. The dividend was paid on 22 May 2024.

Dividend declared on 7 Nov 2023

A dividend of $0.62 per share was announced, adjusted to $0.67. The dividend was paid on 22 Nov 2023.

Earnings released on 30 Sept 2023

EPS came in at $0.39 falling short of the estimated $0.57 by -32.01%, while revenue for the quarter reached $539.98M , beating expectations by +0.32%.

Earnings released on 4 Jul 2023

EPS came in at $0.54 surpassing the estimated $0.53 by +2.66%, while revenue for the quarter reached $537.72M , missing expectations by -0.58%.

Earnings released on 11 May 2023

EPS came in at $0.81 surpassing the estimated $0.64 by +25.78%, while revenue for the quarter reached $599.45M , beating expectations by +0.34%.

Earnings released on 16 Mar 2023

EPS came in at $0.58 surpassing the estimated $0.55 by +6.42%, while revenue for the quarter reached $512.48M , missing expectations by -0.84%.

Dividend declared on 16 Mar 2023

A dividend of $0.65 per share was announced, adjusted to $0.70. The dividend was paid on 24 May 2023.

Dividend declared on 17 Nov 2022

A dividend of $0.56 per share was announced, adjusted to $0.64. The dividend was paid on 23 Nov 2022.

Earnings released on 8 Nov 2022

EPS came in at $0.63 surpassing the estimated $0.53 by +18.64%, while revenue for the quarter reached $473.69M , beating expectations by +7.40%.

Earnings released on 28 Jul 2022

EPS came in at $0.56 surpassing the estimated $0.48 by +16.67%, while revenue for the quarter reached $494.88M , beating expectations by +4.41%.

Earnings released on 10 May 2022

EPS came in at $0.48 falling short of the estimated $0.52 by -8.01%, while revenue for the quarter reached $463.89M , beating expectations by +1.80%.

Dividend declared on 2 May 2022

A dividend of $0.61 per share was announced, adjusted to $0.67. The dividend was paid on 25 May 2022.

Earnings released on 17 Mar 2022

EPS came in at $0.47 falling short of the estimated $0.56 by -15.67%, while revenue for the quarter reached $480.56M , beating expectations by +0.42%.

Dividend declared on 17 Nov 2021

A dividend of $0.60 per share was announced, adjusted to $0.62. The dividend was paid on 24 Nov 2021.

Earnings released on 28 Oct 2021

EPS came in at $0.50 falling short of the estimated $0.56 by -10.45%, while revenue for the quarter reached $447.28M .

Earnings released on 29 Jul 2021

EPS came in at $0.66 surpassing the estimated $0.57 by +16.70%, while revenue for the quarter reached $457.96M .

Earnings released on 6 May 2021

EPS came in at $0.52 falling short of the estimated $0.60 by -13.91%, while revenue for the quarter reached $452.64M .

Dividend declared on 23 Mar 2021

A dividend of $0.67 per share was announced, adjusted to $0.64. The dividend was paid on 26 May 2021.

Earnings released on 18 Mar 2021

EPS came in at $0.47 falling short of the estimated $0.52 by -9.23%, while revenue for the quarter reached $435.42M .

Dividend declared on 19 Nov 2020

A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 25 Nov 2020.

Earnings released on 29 Oct 2020

EPS came in at $0.43 falling short of the estimated $0.53 by -17.72%, while revenue for the quarter reached $391.71M , beating expectations by +6.90K%.

RCDTF Stock Performance

Access detailed RCDTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run